Technology and business development partner to academic/medical institutions, startup companies, and industry.

Worked with colleagues in the Office of the Vice Chancellor for Research and key partners across the university to facilitate the translation of research programs. This involved working with researchers and leadership to identify and examine novel research programs and supporting their advancement through connection with internal and external expertise, resources, and funding.

• Promoted innovation, translation, commercialization, and entrepreneurship through continuous engagement with faculty, leadership, and administration.• Identified, evaluated, and facilitated development of innovative technologies through internal and external grants, resources, and investment. • Worked with experts, advisors, industry, and investors to stimulate and inform translation and commercialization of university technologies and support startup companies.

• Identified and evaluated new technologies, innovations and know-how at Mayo Clinic• Promoted development and translation of technologies using MCV and institutional funding programs, and internal/external networks of resources and experts• Facilitated business development and technology commercialization through networks of industry contacts, investors and entrepreneurs• Promoted startup company formation with entrepreneurs, working with colleagues in MCV and Mayo Clinic Treasury Services• Served on institutional and public funding review panels to provide scientific and commercial perspective• Educated Mayo Clinic staff and raised awareness and understanding of intellectual property, commercialization and available infrastructure

• Conducted and supervised translational laboratory research studying multiple myeloma disease mechanisms and efficacy of numerous preclinical drug candidates

• As Business Unit Manager, managed operations, finances, and strategic objectives for the hepatitis C business unit• Directed scientists, lab technicians, manufacturing and quality testing personnel• Developed strategic objectives with support areas including planning, manufacturing engineering, software, quality, regulatory affairs, and marketing in the USA, Germany, Ireland, and Japan• Improved pipeline and product availability with annual sales exceeding $100M (#1 in division)• Developed method characterizations and test method validations for new product testing• Prepared data packages for PMA and PLA FDA submissions and amendments• Served on multiple committees to assure division compliance with FDA quality system regulations• In an operations support role, provided strategic and scientific support for product development, design control activities, product launches, and on-market product in the hepatitis C business unit • Supported new product and platform development• Managed testing and manufacturing personnel• Maintained FDA and international regulatory agency compliance for manufacturing and laboratory testing of on-market products and products in development• Interacted with internal and external auditing groups including the FDA• Completed multiple domestic and international product design changes under new FDA guidelines and device clinical studies by heading cross-functional teams comprised of numerous support areas • Conducted field travel to support customers and troubleshoot issues• Presented information on hepatitis, hepatitis assays, and relevant technologies at regional and national meetings• Completed numerous training programs for management, FDA compliance, and lean initiatives